Jeong, Ga Ram Jang, Eun-Hae Bae, Jae Ryul Jun, Soyoung Kang, Ho Chul Park, Chi-Hu Shin, Joo-Ho Yamamoto, Yukio Tanaka-Yamamoto, Keiko Dawson, Valina L. Dawson, Ted M. Hur, Eun-Mi Lee, Byoung Dae 2024-01-19T23:31:14Z 2024-01-19T23:31:14Z 2021-09-03 2018-02-13 1750-1326 https://pubs.kist.re.kr/handle/201004/121703 Background: Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial and sporadic Parkinson's disease (PD). Elevated kinase activity is associated with LRRK2 toxicity, but the substrates that mediate neurodegeneration remain poorly defined. Given the increasing evidence suggesting a role of LRRK2 in membrane and vesicle trafficking, here we systemically screened Rab GTPases, core regulators of vesicular dynamics, as potential substrates of LRRK2 and investigated the functional consequence of such phosphorylation in cells and in vivo. Methods: In vitro LRRK2 kinase assay with forty-five purified human Rab GTPases was performed to identify Rab family proteins as substrates of LRRK2. We identified the phosphorylation site by tandem mass-spectrometry and confirmed it by assessing phosphorylation in the in vitro LRRK2 kinase assay and in cells. Effects of Rab phosphorylation on neurodegeneration were examined in primary cultures and in vivo by intracranial injection of adeno-associated viral vectors (AAV) expressing wild-type or phosphomutants of Rab35. Results: Our screening revealed that LRRK2 phosphorylated several Rab GTPases at a conserved threonine residue in the switch II region, and by using the kinase-inactive LRRK2-D1994A and the pathogenic LRRK2-G2019S along with Rab proteins in which the LRRK2 site was mutated, we verified that a subset of Rab proteins, including Rab35, were authentic substrates of LRRK2 both in vitro and in cells. We also showed that phosphorylation of Rab regulated GDP/GTP-binding property in cells. Moreover, in primary cortical neurons, mutation of the LRRK2 site in several Rabs caused neurotoxicity, which was most severely induced by phosphomutants of Rab35. Furthermore, intracranial injection of the AAV-Rab35-T72A or AAV-Rab35-T72D into the substantia nigra substantially induced degeneration of dopaminergic neurons in vivo. Conclusions: Here we show that a subset of Rab GTPases are authentic substrates of LRRK2 both in vitro and in cells. We also provide evidence that dysregulation of Rab phosphorylation in the LRRK2 site induces neurotoxicity in primary neurons and degeneration of dopaminergic neurons in vivo. Our study suggests that Rab GTPases might mediate LRRK2 toxicity in the progression of PD. English BMC PARKINSONS-DISEASE ALPHA-SYNUCLEIN KINASE-ACTIVITY PROTEIN-KINASE LOCALIZATION MUTATIONS TRAFFICKING REGULATOR SECRETION ENDOSOMES Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration Article 10.1186/s13024-018-0240-1 1 MOLECULAR NEURODEGENERATION, v.13 MOLECULAR NEURODEGENERATION 13 scie scopus 000425460200001 2-s2.0-85042015038 Neurosciences Neurosciences & Neurology Article PARKINSONS-DISEASE ALPHA-SYNUCLEIN KINASE-ACTIVITY PROTEIN-KINASE LOCALIZATION MUTATIONS TRAFFICKING REGULATOR SECRETION ENDOSOMES LRRK2 Rab GTPases Phosphorylation Neurodegeneration Parkinson&apos s disease